Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting 2025-05-23 17:24
Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025 2025-05-23 12:31
Everest Medicines Announces NEFECON® Inclusion in China's Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review) 2025-05-23 11:39
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting 2025-05-23 08:00
Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases 2025-05-22 23:47
Pictor Establishes U.S. Headquarters and Scales Operations, Revolutionizing Proteomics Testing Amid Regulatory Shift 2025-05-22 21:42
EdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CRO 2025-05-22 20:20
Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation 2025-05-22 10:09
AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients 2025-05-22 09:21
PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response 2025-05-20 22:22
Global Bakery Expo Spotlight: Angel Yeast Launches Feravor™ – A Revolutionary Natural Flavor Solution for Clean-Label Baking 2025-05-20 21:54
Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-022 (CLDN18.2 ADC) In Combination with KEYTRUDA® (pembrolizumab) 2025-05-20 20:00
Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity 2025-05-20 18:00
SPOT-MAS Lung: AI-Powered Blood Test Brings New Hope to High-Risk Non-Smokers in Asia 2025-05-20 10:55
PHASE Scientific Raises US$34 Million Series A Round to Advance Urine-Based Diagnostic Technology for Early Disease Detection 2025-05-20 09:03
Telix at ANZSNM Annual Scientific Meeting 2025 2025-05-20 06:00
Shanton to Present Topline Data from Phase 2b Study with SAP-001 in Refractory Gout Patients at EULAR 2025 Congress 2025-05-19 21:00
Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation 2025-05-19 08:00
Gene Solutions and NEWCL Forge Strategic Partnership to Advance Genetic Testing in Taiwan 2025-05-16 19:06
Genome & Company's Skincare Brand UIQ Expands into North America with Official Amazon Brand Store Launch 2025-05-16 16:00
1 18 19 20 21 22 264